$VRTX · Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated filed a Form 3 with the SEC on October 22, 2026, for Daniel J. Brennan. The filing is an initial statement of beneficial ownership, which is required when a person becomes a director, officer, or 10% owner of a public company. According to the form, Brennan became a director of Vertex Pharmaceuticals on October 20, 2026.
The filing states that Brennan does not beneficially own any non-derivative or derivative securities of Vertex. Both tables in the filing are empty, and the explanation of responses includes the note: “No securities are beneficially owned.” The form was signed by Christiana Stevenson as attorney-in-fact on Brennan’s behalf.